COVID-19 Raises Heart Risks for Years After Infection

The Heart After COVID: A Year of Hidden Risk

Two years ago, Ziyad Al-Aly and his team at the VA St. Louis Health Care System dropped a bomb on how we understand COVID-19. They showed that a single infection could leave people with a dramatically increased risk of diabetes, kidney disease, and blood clots for months afterward. The paper was cited over 2,000 times. It changed clinical guidelines. It made people afraid of getting sick in a new way.

Now they have done it again. This time, they looked at the heart.

The new study, published in Nature Medicine and led by Yan Xie, Evan Xu, Benjamin Bowe, and Ziyad Al-Aly (Xie et al., 2022), tracked 153,760 people who survived the first 30 days of COVID-19. They compared them against two control groups: a contemporary group of 5.6 million people who never had COVID, and a historical group of 5.8 million people from before the pandemic. What they found is not subtle. It is not a marginal increase. It is a sustained, measurable assault on the cardiovascular system that lasts at least a year.

Here is the headline: People who had COVID-19 had a 63% higher risk of a major adverse cardiovascular event over the next 12 months compared to people who never got infected. That includes heart attacks, strokes, and death from heart-related causes. But the real story is in the details. The risk was elevated across every single category of cardiovascular disease the authors examined: heart failure, arrhythmias, pulmonary embolism, pericarditis, myocarditis, even ischemic and non-ischemic heart disease.

And here is the part that should make you sit up straight: This was true even for people who were never sick enough to be hospitalized. The mild cases, the ones that felt like a bad cold, the ones that barely registered on a pulse oximeter. Those people also carried a higher risk.

What the Study Actually Did

The data comes from the US Department of Veterans Affairs national healthcare databases. That is a massive, centralized system covering millions of people with consistent records. The team built a cohort of 153,760 veterans who tested positive for COVID-19 between March 1, 2020, and January 15, 2021, and who survived the first 30 days after infection. Then they matched them against two control groups, each containing over 5.5 million people.

The contemporary controls were people who used the VA healthcare system during the same period but never tested positive for COVID. The historical controls were people from 2017, before the virus existed. This double control is important. It accounts for the possibility that people who get tested for COVID are different from people who do not. It also accounts for the fact that the pandemic itself changed healthcare utilization patterns.

The authors then tracked these people for 12 months, looking for 20 different cardiovascular outcomes. They adjusted for age, sex, race, smoking, obesity, diabetes, hypertension, kidney disease, and a long list of other pre-existing conditions. They were not comparing sick people to healthy people. They were comparing people who were similar in almost every way, except for the virus.

The Numbers, Laid Out

Here is what the data showed for the one-year period after the first 30 days of infection:

• ▸Heart failure: 72% higher risk (Xie et al., 2022)
• ▸Pulmonary embolism: 2.5 times higher risk
• ▸Arrhythmias: 69% higher risk
• ▸Stroke: 53% higher risk
• ▸Myocarditis and pericarditis: 3.4 times higher risk
• ▸Any major adverse cardiovascular event: 63% higher risk

These are not small effects. A 63% increase means that if the baseline risk in the control group was 1 event per 100 people per year, the COVID group had 1.63 events per 100 people per year. That is an extra 6.3 events per 1,000 people. Over a population of millions, that is a lot of hearts.

The authors also calculated the 1-year burden. For every 1,000 people with COVID-19, there were an additional 23 cardiovascular events over the next year. That includes 5 extra heart failures, 4 extra pulmonary embolisms, 4 extra arrhythmias, and 3 extra strokes. The burden was highest in people who had been hospitalized, but it was present even in those who were never admitted.

The Graded Risk: How Severity Matters

One of the most striking findings is the graded relationship between acute COVID severity and long-term heart risk. The authors broke the COVID group into three categories based on care setting during the acute phase: non-hospitalized, hospitalized, and admitted to intensive care (Xie et al., 2022).

The non-hospitalized group, people who had mild enough cases to stay home, still showed elevated risk. Their hazard ratio for any cardiovascular outcome was 1.41, meaning a 41% increase compared to controls. The hospitalized group had a hazard ratio of 2.51. The ICU group had a hazard ratio of 4.37.

This gradient tells us something important. It suggests that the severity of the acute infection correlates with the magnitude of long-term damage. But it also tells us that even mild infections leave a mark. The virus does not need to put you in the hospital to affect your heart.

What This Means for the "Mild Case" Narrative

Throughout the pandemic, public health messaging has drawn a sharp line between mild and severe COVID. Mild meant you stayed home. Severe meant you needed oxygen. The implicit message was that mild cases were essentially harmless. This study challenges that assumption directly.

The authors found that even among people who were never hospitalized, the risk of a pulmonary embolism was 2.1 times higher than controls. The risk of myocarditis was 2.8 times higher. These are not trivial outcomes. A pulmonary embolism can kill you. Myocarditis can permanently damage your heart muscle.

This does not mean that every mild case leads to heart disease. The absolute risk remains low. But the relative increase is real, and it is consistent across multiple cardiovascular conditions.

Why Does COVID Do This to the Heart?

The study does not answer the mechanism question directly, but the authors offer some hypotheses. The prevailing theory is that the virus triggers a persistent inflammatory response. Even after the acute infection clears, the immune system remains in a state of heightened activation. This chronic inflammation can damage the lining of blood vessels, promote clot formation, and stress the heart muscle.

There is also evidence that the virus can directly infect heart cells. Autopsy studies have found viral RNA in cardiac tissue months after infection. The virus may also trigger an autoimmune response, where the immune system attacks healthy heart tissue.

What is clear from this study is that the damage is not limited to the acute phase. The heart does not just recover once the fever breaks. For many people, the risk persists for at least a year.

The Burden Is Not Equal for Everyone

The authors stratified their results by age, sex, and race. The risk was elevated across all groups, but some carried a heavier burden. Older adults had a higher absolute risk, meaning the same relative increase translated into more events. Men had a slightly higher risk than women. Black veterans had a higher risk than white veterans.

This is consistent with what we know about COVID-19 in general. The virus does not hit everyone equally. But the study adds a new layer: The long-term cardiovascular consequences also follow these disparities.

What This Study Does Not Prove

This is a large, well-designed observational study. But it is not a randomized trial. The authors cannot prove that COVID-19 causes these heart problems. They can only show a strong association.

There is also the question of the study population. The VA cohort is overwhelmingly male (88%) and older (median age 61). The results may not generalize perfectly to younger women or children. The authors note this limitation themselves.

Another important caveat: The study covers the period before widespread vaccination. It is possible that vaccination reduces the long-term cardiovascular risk, either by preventing infection altogether or by reducing the severity of breakthrough cases. The authors did not test this directly.

Finally, the study only followed people for one year. We do not know if the risk persists beyond that. It could plateau. It could decline. It could even increase. The authors are planning longer follow-up studies.

The Clinical Implications

This study should change how doctors think about COVID survivors. The current standard of care for someone who had a mild case is essentially nothing. No follow-up. No cardiac screening. No monitoring. The assumption is that once you are negative, you are fine.

The authors argue that this is insufficient. They write that "care pathways of those surviving the acute episode of COVID-19 should include attention to cardiovascular health and disease" (Xie et al., 2022). This is not a vague recommendation. It is a call for specific action.

What should that action look like? The authors do not prescribe a protocol, but the data suggests some obvious steps. Patients with COVID-19 should be informed about the elevated risk. They should be monitored for symptoms like chest pain, shortness of breath, and palpitations. Those with pre-existing cardiovascular risk factors may benefit from more aggressive management of blood pressure, cholesterol, and diabetes.

The study also raises questions about the use of prophylactic medications. Should COVID survivors take low-dose aspirin to reduce clot risk? Should they be on statins? These are questions for future trials, but the data makes them worth asking.

What This Actually Means

• ▸If you had COVID, your heart risk is higher for at least a year. This is not anxiety. It is data. Know the symptoms of heart attack and stroke. Do not ignore chest pain or shortness of breath.

• ▸Mild cases are not harmless. The risk is lower than for severe cases, but it is real. Do not assume that because you never needed a hospital, you are in the clear.

• ▸Doctors should screen COVID survivors for cardiovascular issues. A simple conversation about symptoms and a blood pressure check could catch problems early. This should become standard practice.

• ▸Vaccination probably reduces this risk. The study was done before vaccines were widely available. Getting vaccinated and boosted likely lowers the chance of long-term cardiac complications, both by preventing infection and by reducing severity.

• ▸This is not a reason to panic, but it is a reason to pay attention. The absolute risk is still low. Most people who had COVID will not have a heart attack. But the risk is real, and it is preventable. Awareness is the first step.